drugset / Trial / NCT00669162
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
Following a radical prostatectomy and lymph node sampling, eligible patients will undergo post-operative radiation therapy, concurrent weekly docetaxel chemotherapy , and hormonal therapy (Casodex daily and Zoladex every 3 months for 2 times or Lupron 22.5 mg im every 3 months for 2 times).
Timeline
- Start
- 2012-08
- Primary completion
- 2016-08
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | 50 mg | Oral |
| Subject | Docetaxel | Small molecule | 20 mg/m2 | Intravenous |
| Subject | Goserelin | Other / unclassified | 10.8 mg | Subcutaneous |
| Subject | Leuprolide | Other / unclassified | 22.5 mg | Intramuscular |